Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8


Making progress in treating multiple myeloma with total therapies: issue of complete remission and more.

Barlogie B, van Rhee F, Shaughnessy JD Jr, Anaissie E, Crowley J.

Leukemia. 2008 Aug;22(8):1633-6. doi: 10.1038/leu.2008.40. Epub 2008 Feb 28. No abstract available. Erratum in: Leukemia. 2008 Aug;22(8):1650.


Role of autologous stem-cell transplantation in multiple myeloma.

Attal M, Harousseau JL.

Best Pract Res Clin Haematol. 2007 Dec;20(4):747-59. Review.


New drugs for myeloma.

Richardson PG, Mitsiades C, Schlossman R, Munshi N, Anderson K.

Oncologist. 2007 Jun;12(6):664-89. Review.


Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.

Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD Jr, Epstein J, van Hemert R, Erdem E, Hoering A, Crowley J, Ferris E, Hollmig K, van Rhee F, Zangari M, Pineda-Roman M, Mohiuddin A, Yaccoby S, Sawyer J, Angtuaco EJ.

J Clin Oncol. 2007 Mar 20;25(9):1121-8. Epub 2007 Feb 12.


A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

Shaughnessy JD Jr, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, Stewart JP, Kordsmeier B, Randolph C, Williams DR, Xiao Y, Xu H, Epstein J, Anaissie E, Krishna SG, Cottler-Fox M, Hollmig K, Mohiuddin A, Pineda-Roman M, Tricot G, van Rhee F, Sawyer J, Alsayed Y, Walker R, Zangari M, Crowley J, Barlogie B.

Blood. 2007 Mar 15;109(6):2276-84. Epub 2006 Nov 14.


Thalidomide and hematopoietic-cell transplantation for multiple myeloma.

Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F, Fassas A, Zangari M, Hollmig K, Pineda-Roman M, Lee C, Talamo G, Thertulien R, Kiwan E, Krishna S, Fox M, Crowley J.

N Engl J Med. 2006 Mar 9;354(10):1021-30.


The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr.

N Engl J Med. 2003 Dec 25;349(26):2483-94.


Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma.

Cavo M, Terragna C, Martinelli G, Ronconi S, Zamagni E, Tosi P, Lemoli RM, Benni M, Pagliani G, Bandini G, Tura S.

Blood. 2000 Jul 1;96(1):355-7.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk